| http://dbpedia.org/ontology/abstract
|
Imugene Ltd is a biotechnology company wor … Imugene Ltd is a biotechnology company working in cancer immunotherapy. The company's lead product is HER-Vaxx, a therapeutic cancer vaccine for the treatment of gastric cancer and breast cancer, where the cancer is HER-2-positive. Imugene was planning a Phase Ib/II clinical study of HER-Vaxx in gastric cancer which it intended to initiate in 2016. Imugene stock is publicly traded on the Australian Securities Exchange (ASX). the Australian Securities Exchange (ASX).
|
| http://dbpedia.org/ontology/foundingYear
|
2012
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Christoph_Zielinski +
, http://dbpedia.org/resource/Axel_Hoos +
, http://dbpedia.org/resource/Executive_chairman +
, http://dbpedia.org/resource/Paul_A._Hopper +
, http://dbpedia.org/resource/Ursula_Wiedermann +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Melbourne +
|
| http://dbpedia.org/ontology/wikiPageID
|
48703744
|
| http://dbpedia.org/ontology/wikiPageLength
|
9820
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1121552074
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Australian_Securities_Exchange +
, http://dbpedia.org/resource/Yervoy +
, http://dbpedia.org/resource/Reverse_takeover +
, http://dbpedia.org/resource/Bristol-Myers_Squibb +
, http://dbpedia.org/resource/Perjeta +
, http://dbpedia.org/resource/Interferon_gamma +
, http://dbpedia.org/resource/Christoph_Zielinski +
, http://dbpedia.org/resource/Ursula_Wiedermann +
, http://dbpedia.org/resource/Category:Cancer_organisations_based_in_Australia +
, http://dbpedia.org/resource/Executive_chairman +
, http://dbpedia.org/resource/CRM197 +
, http://dbpedia.org/resource/Peptide_vaccine +
, http://dbpedia.org/resource/Tumor_necrosis_factor_alpha +
, http://dbpedia.org/resource/Memorial_Sloan_Kettering_Cancer_Center +
, http://dbpedia.org/resource/Axel_Hoos +
, http://dbpedia.org/resource/Genentech +
, http://dbpedia.org/resource/Peptide +
, http://dbpedia.org/resource/Immunotherapy +
, http://dbpedia.org/resource/Cancer_vaccine +
, http://dbpedia.org/resource/HER-2 +
, http://dbpedia.org/resource/Paul_A._Hopper +
, http://dbpedia.org/resource/Antigen +
, http://dbpedia.org/resource/Melbourne +
, http://dbpedia.org/resource/Medical_University_of_Vienna +
, http://dbpedia.org/resource/Herceptin +
, http://dbpedia.org/resource/Interleukin_2 +
, http://dbpedia.org/resource/Adjuvant +
, http://dbpedia.org/resource/B_cell +
, http://dbpedia.org/resource/Epitope +
, http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/foundation
|
2012
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
http://dbpedia.org/resource/Paul_A._Hopper +
, http://dbpedia.org/resource/Ursula_Wiedermann +
, http://dbpedia.org/resource/Christoph_Zielinski +
, http://dbpedia.org/resource/Axel_Hoos +
, Leslie Chong
|
| http://dbpedia.org/property/location
|
Melbourne, Australia
|
| http://dbpedia.org/property/name
|
Imugene Ltd
|
| http://dbpedia.org/property/products
|
HER-Vaxx
|
| http://dbpedia.org/property/type
|
Public company
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:URL +
, http://dbpedia.org/resource/Template:Asx +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Third-party +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Cancer_organisations_based_in_Australia +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Imugene?oldid=1121552074&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Imugene +
|
| http://xmlns.com/foaf/0.1/name
|
Imugene Ltd
|
| owl:sameAs |
http://dbpedia.org/resource/Imugene +
, https://global.dbpedia.org/id/2P17H +
, http://yago-knowledge.org/resource/Imugene +
, http://www.wikidata.org/entity/Q25245408 +
|
| rdf:type |
http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/ontology/Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Company +
|
| rdfs:comment |
Imugene Ltd is a biotechnology company wor … Imugene Ltd is a biotechnology company working in cancer immunotherapy. The company's lead product is HER-Vaxx, a therapeutic cancer vaccine for the treatment of gastric cancer and breast cancer, where the cancer is HER-2-positive. Imugene was planning a Phase Ib/II clinical study of HER-Vaxx in gastric cancer which it intended to initiate in 2016. Imugene stock is publicly traded on the Australian Securities Exchange (ASX). the Australian Securities Exchange (ASX).
|
| rdfs:label |
Imugene
|
